Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Davis

Showing results (151-160 of 227) with videos related to

Pageof 23
Sort By:
Hepatology (Baltimore, Md.)|October 26, 2000
Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis CT Poynard, J McHutchison, G L Davis, et al.
Clinical Pharmacology and Therapeutics|April 1, 1985
Effects of influenza virus vaccine on hepatic drug metabolismC G Meredith, C D Christian, R F Johnson, et al.
Thrombosis Research|March 1, 1990
The effects of acute exercise and increased atmospheric pressure on the hemostatic mechanism and plasma catecholamine levelsK A LaCroix, G L Davis, D A Schneider, et al.
Gastroenterology|January 1, 1986
Pilot study of recombinant human alpha-interferon for chronic type B hepatitisJ S Dooley, G L Davis, M Peters, et al.
Journal of Viral Hepatitis|March 1, 1997
Modulation of hepatitis C virus quasispecies heterogeneity by interferon-alpha and ribavirin therapyR P González-Peralta, W Z Liu, G L Davis, et al.
Antiviral Therapy|February 22, 2000
Interferon-alpha therapy exerts selective pressure on hepatitis C virus quasispecies equilibriumM Mizokami, T Ohno, K Ohba, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1986
Immunologic effects of interferon-alpha in man: treatment with human recombinant interferon-alpha suppresses in vitro immunoglobulin production in patients with chronic type B hepatitisM Peters, D M Walling, K Kelly, et al.
Annals of Internal Medicine|February 12, 1998
Estimates of the cost-effectiveness of a single course of interferon-alpha 2b in patients with histologically mild chronic hepatitis CW G Bennett, Y Inoue, J R Beck, et al.
Journal of Hepatology|February 1, 1997
Humoral immunoreactivity to HCV core antigen in patients with chronic hepatitis CC G Marousis, S Quan, G L Davis, et al.
Gastroenterology|May 1, 1983
Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic, and radiologic featuresP Kerlin, G L Davis, D B McGill, et al.
Pageof 23

Showing results (151-160 of 227) with videos related to

Sort By:
Pageof 23
Hepatology (Baltimore, Md.)|October 26, 2000
Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis CT Poynard, J McHutchison, G L Davis, et al.
Clinical Pharmacology and Therapeutics|April 1, 1985
Effects of influenza virus vaccine on hepatic drug metabolismC G Meredith, C D Christian, R F Johnson, et al.
Thrombosis Research|March 1, 1990
The effects of acute exercise and increased atmospheric pressure on the hemostatic mechanism and plasma catecholamine levelsK A LaCroix, G L Davis, D A Schneider, et al.
Gastroenterology|January 1, 1986
Pilot study of recombinant human alpha-interferon for chronic type B hepatitisJ S Dooley, G L Davis, M Peters, et al.
Journal of Viral Hepatitis|March 1, 1997
Modulation of hepatitis C virus quasispecies heterogeneity by interferon-alpha and ribavirin therapyR P González-Peralta, W Z Liu, G L Davis, et al.
Antiviral Therapy|February 22, 2000
Interferon-alpha therapy exerts selective pressure on hepatitis C virus quasispecies equilibriumM Mizokami, T Ohno, K Ohba, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1986
Immunologic effects of interferon-alpha in man: treatment with human recombinant interferon-alpha suppresses in vitro immunoglobulin production in patients with chronic type B hepatitisM Peters, D M Walling, K Kelly, et al.
Annals of Internal Medicine|February 12, 1998
Estimates of the cost-effectiveness of a single course of interferon-alpha 2b in patients with histologically mild chronic hepatitis CW G Bennett, Y Inoue, J R Beck, et al.
Journal of Hepatology|February 1, 1997
Humoral immunoreactivity to HCV core antigen in patients with chronic hepatitis CC G Marousis, S Quan, G L Davis, et al.
Gastroenterology|May 1, 1983
Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic, and radiologic featuresP Kerlin, G L Davis, D B McGill, et al.
Pageof 23